Suchergebnisse - "de Andrade, Danieli"

PubPharm (5)

1

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

enthalten in: Rheumatology (Oxford, England) | 2024

von Balbi, G. | Ahmadzadeh, Y. | Tektonidou, M. | +94

2

Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients : Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Zuo, Y. | Navaz, S. | Tsodikov, A. | +100

CommentIn: Arthritis Rheumatol. 2023 Aug;75(8):1331-1333. - PMID 37192153

3

Immunosuppression use in primary antiphospholipid antibody-positive patients : Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")

enthalten in: Lupus | 2022

von Erton, Z. | K Leaf, R. | de Andrade, D. | +28

4

Cognitive dysfunction and serum levels of brain-derived neurotrophic factor (BDNF) in primary anti-phospholipid syndrome (PAPS)

enthalten in: Rheumatology (Oxford, England) | 2021

von Rosa, R. | Ugolini-Lopes, M. | Gandara, A. | +4

5

Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome : A four-year prospective study

enthalten in: Lupus | 2020

von Nascimento, I. | Radin, M. | Gândara, A. | +2

1
[1]